550 likes | 640 Views
Explore the intricate processes of hemostasis in blood physiology, from vessel wall mechanisms to platelet function and clotting factors. Learn about bleeding disorders and anticoagulants in this comprehensive guide.
E N D
Blood PhysiologyProfessor A.M.A Abdel GaderMD, PhD, FRCP (Lond., Edin), FRSH (London)Professor of Physiology, College of Medicine &King Khalid University HospitalKing Saud UniversityRiyadh
Hemostasis: • the spontaneous arrest of bleeding • from ruptured blood vessels • Mechanisms: • Vessel wall • Platelet • Blood coagulation • Fibrinolytic system
Memostatic Mechanisms: • Mechanisms: • Vessel wall • Platelet • Blood coagulation • Fibrinolytic system
Memostatic Mechanisms- cont • Vessel wall • Immediately After injury a localized Vasoconstriction • Mechanism -Hurmoral factors: • local release of thromboxane A2 & 5HT by platelets • Systemic release of adrenaline • Nervous factors
Platelets – cont. Site of formation: Bone marrow Steps: Stem cell Megakaryoblast Megakaryocyte Platelets
Platelets Thrombocytes are • Fragments of megakaryocytes in bone marrow
Platelets Formation (Thrombopoiesis) Regulation of thrombopoiesis by Thrombombopoietin
Platelet Functions Begins with Platelet activation
Platelet Activation • Adhesion • Shape change • Aggregation • Release • Clot Retraction
Platelet Adhesion • Platelets stick to exposed collagen underlying damaged endothelial cells in vessel wall
Platelet Release Reaction • Platelets activated by adhesion • Extend projections to make contact with each other • Release thromboxane A2, serotonin & ADP activating other platelets • Serotonin & thromboxane A2 are vasoconstrictors decreasing blood flow through the injured vessel. ADP causes stickiness & aggregation
Platelet Aggregation • Activated platelets stick together and activate new platelets to form a mass called a platelet plug • Plug reinforced by fibrin threads formed during clotting process
Platelet Activation • Adhesion • Shape change • Aggregation • Release • Clot Retraction
Platelet • Adhesion Endothelium 2. Shape change • 3. Aggregation
Platelet Plug Aggregation of platelets at the site of injury to stop bleeding • Exposed collagen attracts platelets • Activated platelets release of platelet ADP & TXA2the stickiness of platelets Platelets aggregation plugging of the cut vessel • Intact endothelium secret prostacyclin inhibit aggregation
Activated Platelets Secrets: • 5HT vasoconstriction • Platelet phospholipid (PF3) clot formation • Thromboxane A2 (TXA2) is a prostaglandin formed from arachidonic acid Function of TXA2: • vasoconstriction • Platelet aggregation (TXA2 inhibited by aspirin)
Extrinsic pathway Intrinsic Pathway Tissue factor FXII FXIIa Factor VII & Ca ++ FXI FXIa FIX FIXa FVIII X Xa FV+ Ca+P Prothrombin Thrombin Fibrinogen Fibrin The Coagulation Cascade
The “Cascade”, “Waterfall” model Main feature: Depicts the coagulation process as: a series of proteolytic reactions >> each protease cleaves and activates the subsequent protease
Activation Blood Coagulation • Intrinsic Pathway: all clotting factors present in the blood • Extrinsic Pathway: triggered by tissue factor • Common Pathway
Fibrinolysis Plasminogen activators Plasminogen Plasmin Anti-activators Anti-plasmin Coagulation Fibrin FDP The fibrinolytic System
ANTICOAGULANTS Anticoagulants: Substances that prevent blood coagulation
Anticoagulants-cont. Types: • Substances that remove Ca++ from the blood: Citrate, oxalate, EDTA (Sequestrene) Ethylene Diamine Tetra chloro-Acetate
Anti-coagulants-cont. 2. Heparin • Action: • inhibit the conversion of prothrombin to thrombin • inactivate thrombin (anti-thrombin III) • Uses: • Open heart surgery, Post-operative to prevent deep vein thrombosis • Collection of blood samples in labs.
Anticoagulants-cont. 3. Warfarin • Inhibits the synthesis of Vit-K dependent clotting Factors (II, VII, IX & X) by the liver • Widely used in medicine as a oral anticoagulant
Anticoagulants-cont. 4.Naturally occurring anticoagulants: • Control intravascular clotting • Antithrombin III inhibit thrombin, X, VIII, IX, XII • Protein C inhibit factor VIII, V
Bleeding Disorders Diseases characterized by excessive bleeding: • Vascular defects • Congenital • Acquired • Platelet defects • Low platelet count Thrombocytopenia 3. Coagulation defects • Congenital • Acquired
3. Coagulation defects • Congenital: • Haemophilia A(deficient factor VIII), • Haemophilia B (deficient factor IX, Chrismas Disease) Treatment: • Replacing the missing factor • Transfusing: fresh frozen plasma, clotting factor concentrate